Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review

European Journal of Clinical Pharmacology(2022)10.1007/s00228-022-03346-7Source: DataRank Database

Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review is a research paper published in European Journal of Clinical Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.87)OA: greenTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Seonkyeong Yang ORCID,Shirly Ly,Ryan H. Yoo,Wei‐Hsuan Lo‐Ciganic ORCID,Michael T. Eadon ORCID

Live enrichment

PubMed:35657416 PMC:PMC9283278 OpenAlex:https://openalex.org/W4281716109

National Institutes of Health, National Center for Advancing Translational Sciences

Grant: UL1TR002529

National Institutes of Health

Grant: 5UL1TR002529-02

Indiana Clinical and Translational Sciences Institute

FWCI

0.87

Citation Percentile

0.6%

Citation Trend

2023

2024

2025

2026

greenLicense: Springer TDM

repositoryhttps://scholarworks.indianapolis.iu.edu/bitstreams/18fafcb1-4611-44b6-97e4-0a4bb13b2ca2/download

publisherhttps://link.springer.com/content/pdf/10.1007/s00228-022-03346-7.pdf

publisherhttps://link.springer.com/article/10.1007/s00228-022-03346-7/fulltext.html

repositoryhttps://hdl.handle.net/1805/38989

Fields of Study

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease ManagementPlatelet Disorders and Treatments03 medical and health sciences0302 clinical medicine

MeSH Terms

ClopidogrelGenotypeHumansPlatelet Aggregation InhibitorsPolymorphism, GeneticTreatment OutcomePeripheral Arterial DiseaseCytochrome P-450 CYP2C19

Keywords

ClopidogrelMedicineObservational studyCYP2C19Meta-analysisInternal medicineRandomized controlled trialPopulationIntensive care medicineAspirinRestenosisOcclusionPeripheral Artery DiseaseEffectiveness And SafetyPolymorphism, GeneticGenotypeCytochrome P-450 CYP2C19Peripheral Arterial DiseaseTreatment OutcomeHumansPlatelet Aggregation Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being